SC 13G

Company

Dare Bioscience, Inc.

Filed

February 22, 2018

Accession Number

0001104659-18-011232

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →